Skip to main content
. 2018 Mar 15;8:95–103. doi: 10.1016/j.bonr.2018.03.002

Fig. 1.

Fig. 1

Effect of Scl-Ab treatment on cortical bone formation and mass. (A) Cortical volumetric BMC. (B) Cortical area. (C) Periosteal perimeter. (D) Endocortical perimeter. (E) Cortical Ps.L.Pm. (F) Cortical Ec.L.Pm. (G) Vertebral cancellous MS/BS. (H) Percent change in BMC. Data are mean ± standard deviation. *p ≤ 0.05. Vertical dotted line separates the TP on the left from the TFP on the right.